{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:45:33Z","timestamp":1782513933546,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T00:00:00Z","timestamp":1583539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100016387","name":"Grifols","doi-asserted-by":"crossref","award":["Investigator Initiated Grant"],"award-info":[{"award-number":["Investigator Initiated Grant"]}],"id":[{"id":"10.13039\/501100016387","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s10620-020-06168-8","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T10:02:55Z","timestamp":1583575375000},"page":"2571-2579","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Underutilization of Hospice in Inpatients with Cirrhosis: The NACSELD Experience"],"prefix":"10.1007","volume":"65","author":[{"given":"Jacqueline G.","family":"O\u2019Leary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneeta","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Rajender","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Biggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Kamath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guadalupe","family":"Garcia-Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Maliakkal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo E.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thuluvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leroy R.","family":"Thacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmohan S.","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,7]]},"reference":[{"key":"6168_CR1","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1002\/hep.28812","volume":"64","author":"AM Allen","year":"2016","unstructured":"Allen AM, Kim WR, Moriarty JP, et al. Time trends in the health care burden and mortality of acute on chronic liver failure in the United States. Hepatology. 2016;64:2165\u20132172.","journal-title":"Hepatology"},{"key":"6168_CR2","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1053\/j.gastro.2018.05.032","volume":"155","author":"SK Asrani","year":"2018","unstructured":"Asrani SK, Kouznetsova M, Ogola G, et al. Increasing health care burden of chronic liver disease compared with other chronic diseases, 2004\u20132013. Gastroenterology. 2018;155:719\u2013729.","journal-title":"Gastroenterology"},{"key":"6168_CR3","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.1002\/hep.29773","volume":"67","author":"JG O\u2019Leary","year":"2018","unstructured":"O\u2019Leary JG, Reddy KR, Garcia-Tsao G, et al. NACSELD acute-on-chronic liver failure (NACSELD-ACLF) score predicts 30-day survival in hospitalized patients with cirrhosis. Hepatology. 2018;67:2367\u20132374.","journal-title":"Hepatology"},{"key":"6168_CR4","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/hep.27077","volume":"60","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS, O\u2019Leary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60:250\u2013256.","journal-title":"Hepatology"},{"key":"6168_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/hep.28414","volume":"64","author":"JS Bajaj","year":"2016","unstructured":"Bajaj JS, Reddy KR, Tandon P, et al. The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis. Hepatology. 2016;64:200\u2013208.","journal-title":"Hepatology"},{"key":"6168_CR6","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/hep.29466","volume":"67","author":"C Estes","year":"2018","unstructured":"Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67:123\u2013133.","journal-title":"Hepatology"},{"key":"6168_CR7","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1038\/ajg.2017.290","volume":"112","author":"N Fukui","year":"2017","unstructured":"Fukui N, Golabi P, Otgonsuren M, et al. Demographics, resource utilization, and outcomes of elderly patients with chronic liver disease receiving hospice care in the United States. Am J Gastroenterol. 2017;112:1700\u20131708.","journal-title":"Am J Gastroenterol"},{"key":"6168_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1089\/jpm.2017.0656","volume":"21","author":"SK Mudumbi","year":"2018","unstructured":"Mudumbi SK, Bourgeois CE, Hoppman NA, et al. Palliative care and hospice interventions in decompensated cirrhosis and hepatocellular carcinoma: a rapid review of literature. J Palliat Med. 2018;21:1177\u20131184.","journal-title":"J Palliat Med"},{"key":"6168_CR9","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377\u2013381.","journal-title":"J Biomed Inform"},{"key":"6168_CR10","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1002\/hep.25947","volume":"56","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, O\u2019Leary JG, Reddy KR, et al. Second infections independently increase mortality in hospitalized patients with cirrhosis: the North American consortium for the study of end-stage liver disease (NACSELD) experience. Hepatology. 2012;56:2328\u20132335.","journal-title":"Hepatology"},{"key":"6168_CR11","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cgh.2016.09.157","volume":"15","author":"JS Bajaj","year":"2017","unstructured":"Bajaj JS, O\u2019Leary JG, Tandon P, et al. Hepatic encephalopathy is associated with mortality in patients with cirrhosis independent of other extrahepatic organ failures. Clin Gastroenterol Hepatol. 2017;15:565\u2013574.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6168_CR12","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMoa0801209","volume":"359","author":"WR Kim","year":"2008","unstructured":"Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018\u20131026.","journal-title":"N Engl J Med"},{"key":"6168_CR13","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","volume":"130","author":"SW Biggins","year":"2006","unstructured":"Biggins SW, Kim WR, Terrault NA, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652\u20131660.","journal-title":"Gastroenterology"},{"key":"6168_CR14","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1053\/j.gastro.2009.01.043","volume":"136","author":"JG Abraldes","year":"2009","unstructured":"Abraldes JG, Albillos A, Banares R, et al. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial. Gastroenterology. 2009;136:1651\u20131658.","journal-title":"Gastroenterology"},{"key":"6168_CR15","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1002\/hep.29172","volume":"66","author":"FM Chang","year":"2017","unstructured":"Chang FM, Wang YP, Lang HC, et al. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: a population-based study. Hepatology. 2017;66:896\u2013907.","journal-title":"Hepatology"},{"key":"6168_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1111\/apt.15326","volume":"50","author":"S Salehi","year":"2019","unstructured":"Salehi S, Tranah TH, Lim S, et al. Rifaximin reduces the incidence of spontaneous bacterial peritonitis, variceal bleeding and all-cause admissions in patients on the liver transplant waiting list. Aliment Pharmacol Ther. 2019;50:435\u2013441.","journal-title":"Aliment Pharmacol Ther"},{"key":"6168_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1007\/s11938-018-0180-4","volume":"16","author":"C Moctezuma-Velazquez","year":"2018","unstructured":"Moctezuma-Velazquez C, Abraldes JG, Montano-Loza AJ. The use of statins in patients with chronic liver disease and cirrhosis. Curr Treat Options Gastroenterol. 2018;16:226\u2013240.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"6168_CR18","doi-asserted-by":"publisher","first-page":"e187","DOI":"10.1038\/ctg.2016.44","volume":"7","author":"DJ Kang","year":"2016","unstructured":"Kang DJ, Kakiyama G, Betrapally NS, et al. Rifaximin exerts beneficial effects independent of its ability to alter microbiota composition. Clin Transl Gastroenterol. 2016;7:e187.","journal-title":"Clin Transl Gastroenterol"},{"key":"6168_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.jpainsymman.2016.03.013","volume":"52","author":"CL Brown","year":"2016","unstructured":"Brown CL, Hammill BG, Qualls LG, et al. Significant morbidity and mortality among hospitalized end-stage liver disease patients in medicare. J Pain Symptom Manag. 2016;52:412\u2013419.","journal-title":"J Pain Symptom Manag"},{"key":"6168_CR20","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jhep.2014.10.047","volume":"62","author":"F Wong","year":"2015","unstructured":"Wong F, O\u2019Leary JG, Reddy KR, et al. A cut-off serum creatinine value of 1.5\u00a0mg\/dl for AKI\u2014to be or not to be. J Hepatol. 2015;62:741\u2013743.","journal-title":"J Hepatol."},{"key":"6168_CR21","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","volume":"62","author":"P Angeli","year":"2015","unstructured":"Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968\u2013974.","journal-title":"J Hepatol"},{"key":"6168_CR22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1038\/ajg.2017.122","volume":"112","author":"F Wong","year":"2017","unstructured":"Wong F, O\u2019Leary JG, Reddy KR, et al. Acute kidney injury in cirrhosis: baseline serum creatinine predicts patient outcomes. Am J Gastroenterol. 2017;112:1103\u20131110.","journal-title":"Am J Gastroenterol"},{"key":"6168_CR23","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","volume":"145","author":"F Wong","year":"2013","unstructured":"Wong F, O\u2019Leary JG, Reddy KR, et al. New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection. Gastroenterology. 2013;145:1280\u20131288.","journal-title":"Gastroenterology"},{"key":"6168_CR24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","volume":"15","author":"P Huelin","year":"2017","unstructured":"Huelin P, Piano S, Sola E, et al. Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure. Clin Gastroenterol Hepatol. 2017;15:438\u2013445.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6168_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/sdi.12224","volume":"27","author":"JM Belcher","year":"2014","unstructured":"Belcher JM. Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates? Semin Dial. 2014;27:288\u2013291.","journal-title":"Semin Dial"},{"key":"6168_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.2215\/CJN.03610417","volume":"13","author":"AS Allegretti","year":"2018","unstructured":"Allegretti AS, Parada XV, Eneanya ND, et al. Prognosis of patients with cirrhosis and AKI who initiate RRT. Clin J Am Soc Nephrol. 2018;13:16\u201325.","journal-title":"Clin J Am Soc Nephrol"},{"key":"6168_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cgh.2014.07.060","volume":"13","author":"JG O\u2019Leary","year":"2015","unstructured":"O\u2019Leary JG, Reddy KR, Wong F, et al. Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2015;13:753\u2013759.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6168_CR28","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1002\/lt.25426","volume":"25","author":"JG O\u2019Leary","year":"2019","unstructured":"O\u2019Leary JG, Bajaj JS, Tandon P, et al. Outcomes after listing for liver transplant in patients with acute-on-chronic liver failure: the multicenter North American Consortium for the study of end-stage liver disease experience. Liver Transpl. 2019;25:571\u2013579.","journal-title":"Liver Transpl"},{"key":"6168_CR29","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.14309\/ajg.0000000000000280","volume":"119","author":"J Bajaj","year":"2019","unstructured":"Bajaj J, O\u2019Leary J, Tandon P, et al. Nosocomial infections are frequent and negatively impact outcomes in hospitalized patients with cirrhosis Am J Gastroenterol. 2019;114:1091\u20131100.","journal-title":"Am J Gastroenterol"},{"key":"6168_CR30","doi-asserted-by":"publisher","first-page":"599","DOI":"10.14309\/ajg.0000000000000044","volume":"114","author":"JS Bajaj","year":"2019","unstructured":"Bajaj JS, Tandon P, O\u2019Leary JG, et al. Outcomes in patients with cirrhosis on primary compared to secondary prophylaxis for spontaneous bacterial peritonitis. Am J Gastroenterol. 2019;114:599\u2013606.","journal-title":"Am J Gastroenterol"},{"key":"6168_CR31","doi-asserted-by":"publisher","first-page":"594","DOI":"10.5500\/wjt.v6.i3.594","volume":"6","author":"P Kathpalia","year":"2016","unstructured":"Kathpalia P, Smith A, Lai JC. Underutilization of palliative care services in the liver transplant population. World J Transplant. 2016;6:594\u2013598.","journal-title":"World J Transplant"},{"key":"6168_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/lt.24139","volume":"21","author":"KR Reddy","year":"2015","unstructured":"Reddy KR, O\u2019Leary JG, Kamath PS, et al. High risk of delisting or death in liver transplant candidates following infections: results from the North American Consortium for the Study of End-Stage Liver Disease. Liver Transpl. 2015;21:881\u2013888.","journal-title":"Liver Transpl"},{"key":"6168_CR33","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1111\/apt.13858","volume":"45","author":"C Acharya","year":"2017","unstructured":"Acharya C, Betrapally NS, Gillevet PM, et al. Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis. Aliment Pharmacol Ther. 2017;45:319\u2013331.","journal-title":"Aliment Pharmacol Ther"},{"key":"6168_CR34","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/apt.12324","volume":"37","author":"JH Lewis","year":"2013","unstructured":"Lewis JH, Stine JG. Review article: prescribing medications in patients with cirrhosis\u2014a practical guide. Aliment Pharmacol Ther. 2013;37:1132\u20131156.","journal-title":"Aliment Pharmacol Ther"},{"key":"6168_CR35","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1111\/liv.12215","volume":"33","author":"SS Rogal","year":"2013","unstructured":"Rogal SS, Winger D, Bielefeldt K, et al. Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use. Liver Int. 2013;33:1497\u20131503.","journal-title":"Liver Int"},{"key":"6168_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/lt.25434","volume":"25","author":"ZP Fricker","year":"2019","unstructured":"Fricker ZP, Serper M. Current knowledge, barriers to implementation, and future directions in palliative care for end-stage liver disease. Liver Transpl. 2019;25:787\u2013796.","journal-title":"Liver Transpl"},{"key":"6168_CR37","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1016\/j.cgh.2017.01.030","volume":"15","author":"AA Patel","year":"2017","unstructured":"Patel AA, Walling AM, Ricks-Oddie J, et al. Palliative care and health care utilization for patients with end-stage liver disease at the end of life. Clin Gastroenterol Hepatol. 2017;15:1612\u20131619.","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06168-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-020-06168-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-020-06168-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T00:58:10Z","timestamp":1615078690000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-020-06168-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,7]]},"references-count":37,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["6168"],"URL":"https:\/\/doi.org\/10.1007\/s10620-020-06168-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,7]]},"assertion":[{"value":"7 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}